The global embolic protection devices market size was estimated to be US$ 0.85 billion in 2020 and is expected to reach US$ 1.85 billion by 2031 at a CAGR of 7.3%.
Embolic protection devices (EPD) confine blood and luminal waste material inside the saphenous vein join (SVG) during stenting to forestall distal embolization.
There are three classes of these devices, including distal impediment devices, distal channels, and proximal impediment devices. The explicit rise in cases of Cardiovascular Infections (CVDs) post corona virus outbreak is set to follow a vertical tendency to serve the market, as cardiovascular illnesses represented a significant percentage of worldwide deaths. With the utilization of embolic protection devices (EPD) through percutaneous cardiovascular techniques, the cases of confusions because of waste being released into the blood circulation system and causing blockages in smaller scaled vessels has diminished. This gadget is extraordinarily intended to catch and wipe out garbage that might be disorganized during medical procedure.
Contego Medical, LLC, one of the significant players, revealed in April 2017 that its most recent gadget, Vanguard IEPa had acquired CE Imprint. Lack of appropriate financial assistance and expansion in transcatheter aortic valve substitution is probably going to hamper the development of the embolic protection devices market during the estimation period.
Expansion in transcatheter aortic valve replacement alongside unfavorable wage provisions will go about as restriction and may ruin the development of the market for coming few years. Solid traction of predominant industry major players in North America will additionally stimulate the embolic protection devices industry development during 2022-2032.
Global Embolic Protection Devices Market Value Share Analysis, by Geography (2022)
The report titled “Global Embolic Protection Devices Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is the historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Embolic Protection Devices Market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global Embolic Protection Devices market is segmented on the basis of type, material, application, indication, end users and region. Based on type, the Embolic Protection Devices market is segmented into distal filter devices, distal occlusion devices and proximal occlusion devices, and others. Based on material, the Embolic Protection Devices market is segmented into nitinol and polyurethane, and others. Based on application type, the Embolic Protection Devices market is segmented into peripheral vascular diseases, neurovascular diseases and cardiovascular diseases, and others. Based on indication type, the Embolic Protection Devices market is segmented into percutaneous coronary, carotid artery, saphenous vein graft diseases, transcather aortic valve replacement and others. Based on end user type, the Embolic Protection Devices market is segmented into hospital, ambulatory surgical centers, and others.
Based on geography, the Global Embolic Protection Devices Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada, and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Global Embolic Protection Devices Market. Further, market share of prominent companies in the Global Embolic Protection Devices Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Embolic Protection Devices companies. The Global Embolic Protection Devices Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the Embolic Protection Devices business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the Global Embolic Protection Devices Market.
The key players of the Global Embolic Protection Devices Market are Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Contego Medical LLC, Innovative Cardiovascular Solutions LLC, Edwards Lifesciences Corporation, Medtronic Inc. and Silk Road Medical Inc, and others.
Global Embolic Protection Devices Market Key Segments:
Based on Type
Based on material Type
Based on Application Type
Based on indication Type
Based on End uses Type
By Region
The global Embolic Protection Device market was worth US$ 0.85 billion in 2020.
The global market for Embolic Protection Device will most likely expand at over 7.3% CAGR through 2032.
Major players operating in the global Embolic Protection Device market include Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Contego Medical LLC, Innovative Cardiovascular Solutions LLC, Edwards Lifesciences Corporation, Medtronic Inc. and Silk Road Medical Inc.
Based on type, the Embolic Protection Device market is segmented into Distal filter devices, Distal occlusion devices and Proximal occlusion devices.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved